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protein via chemoselective cysteine modiﬁcation†
Ramiz I. Nathani, Paul Moody, Vijay Chudasama, Mark E. B. Smith,
Richard J. Fitzmaurice and Stephen Caddick*
Local protein microenvironment is used to control the outcome of reaction between cysteine residues and
2,5-dibromohexanediamide. The diﬀerential reactivity is exploited to introduce two orthogonal reactive
handles onto the surface of a double cysteine mutant of superfolder green ﬂuorescent protein in a
regioselective manner. Subsequent elaboration with commonly used thiol and alkyne containing
reagents aﬀects site-selective protein dual labelling.The development of accessible chemical methodologies that
enable the site-selective labelling of proteins has transformed
the study and utility of these complex biomolecules.1 For
example, N3-acetyl-lysine mimetics can be readily introduced in
a denedmanner to allow researchers to further investigate this
key post–translational modication.2 Whereas, in the arena of
protein therapeutics, the ability to conjugate a drug, probe or
lifetime extension technology to a protein in a controlled
manner generates homogeneous biologics with a range of
functions.3 The site-selective labelling of proteins is typically
achieved by exploiting the unique reactivity of a specic func-
tional group in the protein of interest, e.g. thiols,4 alkenes,5
azides6 or alkynes.7
Even more challenging than the site-selective generation of
singly modied proteins is the homogenous modication of a
protein in multiple distinct positions with diﬀerent probes.
Access to site-selectively dual labelled proteins oﬀers opportu-
nities to perform a range of structural studies, employing
techniques such as Fo¨rster resonance energy transfer to
understand protein structure.7 Such a methodology would also
allow the construction of a range of biologics with dual func-
tion, e.g. theranostics,8 or facilitate the optimal conjugation of
both a drug, or imaging probe, with a lifetime extension
technology.3a
In order to successfully aﬀect site-selective dual labelling of a
protein, two chemoselective, biocompatible processes must be
carried out using either native functional groups or those which
can be readily introduced in a controlled manner. A number ofge London, 20 Gordon Street, London,
l.ac.uk; Fax: +44 (0)20 7679 7463; Tel:
n (ESI) available: LC-MS, ES-MS,
mission spectra for all reactions with
emission spectra of superfolder GFP,
derivatives are given. See DOI:
Chemistry 2013strategies have been developed to address this challenge.
However, many are restricted to modication of protein
termini, via introduction of an N-terminal cysteine and a
C-terminal intein,9 or sortase labelling,10 which can limit their
utility.11 Methods which allow for the selective dual modica-
tion of non-terminal positions are highly desirable as they oﬀer
choice as to the disposition of the modications across the
protein surface, however, this creates additional complexity. In
cases where the protein can be expressed as two separate
soluble fragments, it is possible to label each fragment indi-
vidually and then carry out a ligation to generate the desired
dual labelled protein.12 Approaches using a cysteine/tetracys-
teine orthogonal reaction pair have also been employed.13 The
selective introduction and modication of two non-natural
amino acids provides exquisite selectivities.14 However, such
strategies require custom expression strains and tRNAs to
generate the protein, which can be time consuming and
expensive, and can ultimately result in low expression yields.15
Alternatively, it might be envisaged that, it should be possible to
exploit the diﬀerential nucleophilicity of thiols in double
cysteine mutant proteins. However, this has brought limited
success to date due to the heterogeneity of the modied
protein.16
In this report we describe a fundamentally novel approach to
the site-selective dual labelling of a protein at non-terminal
amino acid positions. Our approach is based on the positioning
of two cysteine mutants within a protein sequence such that the
two cysteines are cleanly converted into two distinct products
upon treatment with a single chemical reagent. More speci-
cally, in the work described herein, a double cysteine mutant of
a protein is initially transformed into a bis-sulfonium using a
simple small molecule reagent. The fate of each sulfonium
thereaer is controlled by the protein microenvironment, i.e.
the sulfonium can either persist as a stable entity or eliminate to
yield dehydroalanine, thus resulting in site-selective dual
functionalisation of a protein based on substrate control. As aChem. Sci., 2013, 4, 3455–3458 | 3455
Scheme 1 Reaction modes of sulfonium 3.
Fig. 1 (a) Surface and (b) stick representation of superfolder green ﬂuorescent
protein (PDB ID: 2B3P)21 showing a-protons of S147 and T230 (green). Protons
were added using PyMOL.23
Scheme 2 Conversion of GFP(T230C, 233D) 6 to GFP(T230Dha, 233D) 7.
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View Article Onlineproof of concept, we have applied this rationale to generate a
site-selectively dual labelled superfolder green uorescent
protein.
Bioconjugation via the selective modication of free cysteine
in proteins has received a great deal of attention due to the
unique reactivity of its thiol side chain,17 and the ease with
which the residue can be selectively introduced via site-directed
mutagenesis. For example, Davis has described the modica-
tion of cysteine 1 to generate dehydroalanine 2, which can then
be used for bioconjugation in a range of protein substrates,
including a single cysteine mutant (S156C) of the protease
subtilisin.18 The formation of dehydroalanine 2 is a conse-
quence of b-elimination of sulfonium 3, generated from reac-
tion of cysteine thiol 1 with 2,5-dibromohexanediamide 4 at pH
8 (Scheme 1).18c However, we have recently discovered that
sulfonium 3, derived from a single cysteine mutant of super-
folder green uorescent protein (S147C), can be isolated and
subsequently used in an alternate bioconjugation strategy, via a
ring opening reaction with azide, to aﬀord an azide function-
alised protein 5 (Scheme 1, see Fig. S7 and S8 in the ESI†).19 We
rationalised that the ability to control the stability of a protein
sulfonium, using the protein's microenvironment, could
therefore oﬀer a new approach to site-selective protein dual
labelling.
Our study began with an attempt to understand the struc-
tural factors eﬀecting the formation of dehydroalanine 2 from a
cysteine derived sulfonium 3 based on our previous observa-
tions and those reported by Davis.5,18a–c As elimination to
dehydroalanine 2 inherently requires loss of the a-proton of
sulfonium 3 we envisaged that its microenvironment may play
an important role in the fate of the sulfonium species. Inter-
estingly, examination of the crystal structures of subtilisin (PDB
ID: 1GCI,20 see ESI†) and superfolder GFP (PDB ID: 2B3P,21
Fig. 1) did indeed highlight diﬀerences in the environments of
the a-protons of the residues S156 and S147, respectively. In
GFP the structured protein b-barrel appears to shield the a-
proton of S147 (green) rendering it inaccessible, solvent acces-
sible surface area ¼ 0.0 A˚2 (calculated using Naccess),21 thus
preventing elimination to dehydroalanine 2. However, in
subtilisin the S156 a-proton appears to be solvent accessible
(see ESI†), solvent accessible surface area ¼ 4.5 A˚2,22 and
therefore a single cysteine mutant at this position is prone to
elimination to give dehydroalanine 2 (Scheme 1).3456 | Chem. Sci., 2013, 4, 3455–3458Using the same analysis, we identied residue T230 of
superfolder GFP (Fig. 1), close to the C-terminus, as having a
solvent accessible a-proton (green), solvent accessible surface
area ¼ 4.3 A˚2.21,22 Thus, in order to evaluate our hypothesis on
the signicance of a-proton accessibility on the fate of sulfo-
nium, we expressed and treated a single cysteine mutant at
position 230, GFP(T230C, 233D) 6, with 2,5-dibromohexane-
diamide (4, 50 eq., 2 h, 37 C). Gratifyingly, this generated
GFP(T230Dha, 233D) 7, as determined by LCMS (observed
28 543, expected 28 541), cleanly, as a single product aer 2.5 h
at 37 C (Scheme 2).†
Equipped with these ndings we sought to explore the use of
controlled sulfonium elimination as an approach for the site-
selective dual labelling of a protein. Thus, we generated double
mutant GFP(S147C, T230C, 233D) 8. Initially, to explore if there
was any diﬀerence in the nucleophilicity of the cysteine thiols at
positions 147 and 230, the double mutant was treated with a
stoichiometric amount of N-methylmaleimide. As a statistical
mixture of products was observed (see ESI, Fig. S10†), this
conrmed that the cysteine thiols exhibited essentially equiva-
lent nucleophilicity and that any observed chemoselectivity
would almost certainly not be due to this factor. Having estab-
lished this, we proceeded to incubate double mutant
GFP(S147C, T230C, 233D) 8 with 2,5-dibromohexanediamide (4,
50 eq., 2 h, 37 C) to see if the results observed on the singleThis journal is ª The Royal Society of Chemistry 2013
Fig. 2 Regioselective dual modiﬁcation of double cysteine GFP mutant 8. (a)
Generation of GFP(S147Azide, T230Dha, 233D) 10 from GFP(S147C, T230C,
233D) 8. (b) SDS-PAGE characterisation of 8, 9 and 10with Coomassie staining. (c)
Raw and (d) deconvoluted MS data for GFP(S147Azide, T230Dha, 233D) 10.
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View Article Onlinemutants at positions 147 and 230 would be translated. To our
delight, we observed formation of dual modied GFP(S147Sulf,
T230Dha, 233D) 9 as the sole identiable product, as deter-
mined by SDS-PAGE and LCMS (observed 28 699, expected
28 697, Fig. 2). Furthermore, direct treatment of GFP(S147Sulf,
T230Dha, 233D) 9 with azide (NaN3, >1000 eq., 37 C, 2 h)
resulted in the addition of a single azide to give GFP(S147Azide,
T230Dha, 233D) 10, a site-selectively dual functionalised
protein bearing orthogonal reactive handles, as determined by
SDS-PAGE and LCMS (observed 28 736, expected 28 739, Fig. 2).Scheme 3 Elaboration of GFP(S147Azide, T230Dha, 233D) 10.
This journal is ª The Royal Society of Chemistry 2013The regioselectivity of the reaction of GFP(S147Sulf, T230Dha,
233D) 9 with azide was ascertained by incubation of a fresh
sample of GFP(T230Dha, 233D) 7 with sodium azide (>1000 eq.,
37 C, 4 h). Cross reaction of azide with dehydroalanine in 7 was
not observed, conrming selective ring opening of position 147
sulfonium in GFP(S147Sulf, T230Dha, 233D) 9 generating
GFP(S147Azide, T230Dha, 233D) 10 (see ESI, Fig. S12†).
We then sought to demonstrate the utility of azide/dehy-
droalanine constructs through elaboration of the protein scaf-
fold via reaction with these two orthogonal groups (Scheme 3).
Thus, we treated GFP(S147Azide, T230Dha, 233D) 10 with
commercially available strained alkyne dye, dibenzylcy-
clooctyne PEG4-Fluor 545 (Jena Biosciences), to aﬀect the
formation of the expected dye-GFP conjugate (observed 29 679,
expected 29 675) through a chemoselective strain-promoted
alkyne-azide cyloaddition. It has previously been demonstrated
that protein dehydroalanines undergo facile conjugation with
free thiols, albeit not in a stereodened manner, allowing
introduction of various thiolated probes.19 Thus, subsequent
addition of a simple thiol, 2-mercaptoethanol, to the interme-
diate Dye-GFP conjugate gave dual labelled GFP 11 (observed
29 755, expected 29 753) decorated with a dye, tetrame-
thylrhodamine, and a thiol in a regioselective manner.†Conclusions
A facile and generally accessible methodology for the site-
selective dual modication of proteins is a hitherto unmet need
and oﬀers a wide range of possibilities for development of new
approaches to chemical biology and for therapeutic develop-
ment. Although other techniques are available to aﬀect the site-
selective dual labelling of a protein, they tend to be limited and
each suﬀer from a number of drawbacks. The strategy for che-
moselective protein dual labelling described herein enables
dual functionalisation using orthogonal reactivity of natural
amino acid side chains under mild conditions, underpinned by
two sequential chemoselective reactions. We are hopeful that
this strategy can be applied to any pair of cysteine residues
wherein one residue has an accessible a-proton, and thus
readily forms dehydroalanine, and the a-proton of the second
residue is suﬃciently shielded, and thus persists as a sulfonium
that can undergo chemoselective ring opening by the addition
of azide. Moreover, the derived azide/dehydroalanine proteins
can be further modied in a chemoselective manner using wellChem. Sci., 2013, 4, 3455–3458 | 3457
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View Article Onlineestablished methods and commercial reagents to aﬀect site-
selective dual labelling in a facile manner.Acknowledgements
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